The Department of the Army Medical Command awarded a firm fixed price definitive contract to Biomerieux Inc., a foreign-owned for-profit manufacturer, to provide a blood culture system and related supplies. The contract has a potential value of $198,337.60 and a completion date of August 14, 2022. The original solicitation was for a blood culture detection system. Biomerieux Inc. is a worldwide leader in in vitro diagnostics and has provided a range of clinical diagnostic testing products,...
The U.S. Department of the Army Medical Command awarded a $247,438.60 firm fixed price purchase order to Biomerieux Inc., a foreign-owned, for-profit manufacturer, for the identification and susceptibility testing of microbes at the Brooke Army Medical Center in JBSA Fort Sam Houston, Texas. The contract does not have a set-aside designation. The original solicitation, W81K00-21-Q-0068, was issued by the Regional Health Contracting Office-Central, seeking reagents compatible with Biomerieux's...
The Department of the Army Medical Command awarded Biomerieux Inc., a foreign-owned for-profit manufacturer, a 6-month firm-fixed-price purchase order contract valued at $247,451.00 for a microbial analyzer and related testing services. The contract does not have a set-aside designation. Biomerieux Inc. has previously provided clinical diagnostic testing products, equipment, and services to federal agencies such as the Departments of Veterans Affairs, Defense, Agriculture, and Health and Human...
This is a firm fixed-price purchase order awarded by the Department of the Army Medical Command to Biomerieux Inc., a foreign-owned, for-profit manufacturer of goods, for the provision of a microbiology analyzer and associated maintenance and supplies. The contract has a potential value of $105,805.80 and a completion date of October 31, 2023. No set-aside designation is mentioned. Biomerieux Inc. is a worldwide leader in in vitro diagnostics, offering clinical testing solutions and equipment,...
The Department of the Army Medical Command awarded a $248,363.85 firm fixed-price purchase order to Biomerieux Inc., a foreign-owned, for-profit manufacturer of goods, to provide microbial reagent consumables. This award was made without a set-aside requirement and is set to be completed by September 30, 2020. The original sources sought notification indicates the Army was conducting market research to identify suppliers capable of leasing a microbial identification and susceptibility...
This is a sole source purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Biomerieux Inc., a foreign-owned for-profit manufacturer of in vitro diagnostic products. The $123,222.49 firm-fixed-price contract is for the provision of Biomerieux's proprietary microbiology and molecular biology testing platforms, reagents, and support services. This contract supports the VA's infectious disease testing and diagnostic requirements. Biomerieux has multiple...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a firm fixed price delivery order contract to Biomerieux Inc., a foreign-owned for-profit manufacturer, for blood culture testing services. The $209,573.49 contract has a completion date of June 30, 2020 and does not utilize a set-aside designation. Through this award, Biomerieux will provide its proprietary microbiology and molecular biology platforms, reagents, and technical support...
This $212,471.20 firm fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic solutions. The contract is for the provision of Biomerieux's proprietary microbiology analyzer equipment, reagents, and technical support services to enable infectious disease testing and identification. This award is associated with Biomerieux's existing indefinite delivery contracts and blanket purchase agreements...
This is a purchase order awarded by the Department of the Army Medical Command to Biomerieux Inc., a foreign-owned, for-profit manufacturer of medical diagnostics, for laboratory analyzers. The contract has a firm-fixed price of $107,591.73 and a completion date of April 29, 2021. There was no set-aside designation for this award. Biomerieux Inc. is a global leader in in vitro diagnostics, providing solutions for medical and industrial applications, including proprietary microbiology...
This is a firm-fixed-price purchase order awarded to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of BioMerieux BACT/ALERT 3D and 3D automated blood culture system supplies and services. The $11,058.64 contract was awarded by the Defense Health Agency, a defense agency, with an ultimate completion date of October 1, 2024. The award does not involve any set-aside designation. Biomerieux Inc., through its Biomerieux, Inc. division, is the prime contractor for this...